The IDSA released 2025 guidelines for treating mild to moderate COVID-19, emphasizing risk-based antiviral use to prevent ...
The year 2025 served as a stark reminder that COVID is no longer the only illness demanding public attention. Over the months, several diseases resurfaced or intensified, some reaching epidemic levels ...
The heavily mutated new BA.3.2 COVID-19 variant, aka "cicada," is circulating in at least 25 U.S. states, the CDC said. What to know about its spread and symptoms.
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from ...
Australian scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results